319 related articles for article (PubMed ID: 37344626)
1. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
Sample RA; Nogueira MF; Mitra RD; Puram SV
Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
[TBL] [Abstract][Full Text] [Related]
2. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
3. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
4. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract][Full Text] [Related]
5. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
Lee JY; Kong G
Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
[TBL] [Abstract][Full Text] [Related]
6. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
Liao TT; Yang MH
Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
[TBL] [Abstract][Full Text] [Related]
8. Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions.
Lee MK; Brown MS; Wilkins OM; Pattabiraman DR; Christensen BC
Epigenomics; 2022 May; 14(9):519-535. PubMed ID: 35382559
[No Abstract] [Full Text] [Related]
9. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
10. Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis.
Nowak E; Bednarek I
Cells; 2021 Dec; 10(12):. PubMed ID: 34943943
[TBL] [Abstract][Full Text] [Related]
11. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
12. Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal Transition.
Katipally RR; Pitroda SP; Weichselbaum RR; Hellman S
Clin Cancer Res; 2023 Aug; 29(15):2761-2766. PubMed ID: 37115507
[TBL] [Abstract][Full Text] [Related]
13. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
Bocci F; Tripathi SC; Vilchez Mercedes SA; George JT; Casabar JP; Wong PK; Hanash SM; Levine H; Onuchic JN; Jolly MK
Integr Biol (Camb); 2019 Jun; 11(6):251-263. PubMed ID: 31329868
[TBL] [Abstract][Full Text] [Related]
14. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
15. Identification of the tumour transition states occurring during EMT.
Pastushenko I; Brisebarre A; Sifrim A; Fioramonti M; Revenco T; Boumahdi S; Van Keymeulen A; Brown D; Moers V; Lemaire S; De Clercq S; Minguijón E; Balsat C; Sokolow Y; Dubois C; De Cock F; Scozzaro S; Sopena F; Lanas A; D'Haene N; Salmon I; Marine JC; Voet T; Sotiropoulou PA; Blanpain C
Nature; 2018 Apr; 556(7702):463-468. PubMed ID: 29670281
[TBL] [Abstract][Full Text] [Related]
16. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of epithelial-mesenchymal transition during cancer development.
Yoodee S; Thongboonkerd V
Int Rev Cell Mol Biol; 2023; 380():1-61. PubMed ID: 37657856
[TBL] [Abstract][Full Text] [Related]
18. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.
Bedi U; Mishra VK; Wasilewski D; Scheel C; Johnsen SA
Oncotarget; 2014 Apr; 5(8):2016-29. PubMed ID: 24840099
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of epithelial-mesenchymal transition.
Sun L; Fang J
Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]